We have located links that may give you full text access.
Effect of Mortality alongside 5-Year Survival Rates and Incidence on the Public's Perceived Benefits of Cancer Screening and Screening Intention: A Web-Based Experimental Study.
Medical Decision Making : An International Journal of the Society for Medical Decision Making 2023 December 30
BACKGROUND: Mortality is critical information in evaluating the benefits of cancer screening. However, 5-y survival rates and incidence, without mortality, have been frequently communicated to the public. Based on the literature that people's perceptions and judgments can be altered by the way of presenting health statistics, the current study examined whether mortality alongside 5-y survival and incidence would influence laypeople's perceptions of the effectiveness of cancer screening and screening intention.
METHODS: In an online-based experimental survey conducted in South Korea in October 2022, 300 adults were randomly assigned to 1 of 2 groups (mortality: no v. yes) to be presented with 3 different cancers (A, B, and C). The perceived effectiveness of cancer screening and screening intention were measured using 7-point scales for each cancer.
RESULTS: Across all cancers, participants in the no-mortality group perceived cancer screening to be more effective and were more willing to undergo screening compared with those in the mortality group, although the results were not statistically significant on the intention.
CONCLUSIONS: In general, mortality had an effect of decreasing the perceived effectiveness of cancer screening and screening intention compared with no mortality, although the effect on the intention was not statistically significant.
IMPLICATIONS: When communicating the benefits of cancer screening to the public, mortality statistics may play a role in mitigating the potentially inflated perception of the benefits of cancer screening and screening intention.
HIGHLIGHTS: Five-year survival rates, either alone or with incidence rates, are frequently communicated to the public in the context of the benefits of cancer screening.However, 5-y survival rates can sometimes be inflated without a reduction in mortality.Including mortality statistics in communications decreased the perceived effectiveness of cancer screening and screening intentions.Mortality information needs to be communicated in the benefits of cancer screening.
METHODS: In an online-based experimental survey conducted in South Korea in October 2022, 300 adults were randomly assigned to 1 of 2 groups (mortality: no v. yes) to be presented with 3 different cancers (A, B, and C). The perceived effectiveness of cancer screening and screening intention were measured using 7-point scales for each cancer.
RESULTS: Across all cancers, participants in the no-mortality group perceived cancer screening to be more effective and were more willing to undergo screening compared with those in the mortality group, although the results were not statistically significant on the intention.
CONCLUSIONS: In general, mortality had an effect of decreasing the perceived effectiveness of cancer screening and screening intention compared with no mortality, although the effect on the intention was not statistically significant.
IMPLICATIONS: When communicating the benefits of cancer screening to the public, mortality statistics may play a role in mitigating the potentially inflated perception of the benefits of cancer screening and screening intention.
HIGHLIGHTS: Five-year survival rates, either alone or with incidence rates, are frequently communicated to the public in the context of the benefits of cancer screening.However, 5-y survival rates can sometimes be inflated without a reduction in mortality.Including mortality statistics in communications decreased the perceived effectiveness of cancer screening and screening intentions.Mortality information needs to be communicated in the benefits of cancer screening.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app